MEG3 and cancer: Li et al revealed that MEG3 and MIAT regulate MAPK9 by interactions with miR-106 to involve in MAPK signaling pathways and LINC00115 might interact with miR-7 to regulate FGF2 to participate in pathways in cancer.[34] These lncRNAs may be underlying therapeutic targets for LUAD functioning as ceRNAs for regulation of miRNA-mRNA.